Type 2 Diabetes

HbA1c Predicts Risk for T2D in African American, White Patients

HbA1c Predicts Risk for T2D in African American, White Patients

By

Investigators believe that type 2 diabetes risk assessment would be optimal with fasting glucose and HbA1c levels.

Remotely Connected Diabetes System Improves Glycemic Control in Insulin-Treated Diabetes

Remotely Connected Diabetes System Improves Glycemic Control in Insulin-Treated Diabetes

By

A remotely connected diabetes management system increased patent satisfaction and improved glycemic control in patients with insulin-treated diabetes.

DPP4 Inhibitors Provide Greater Long-Term Glycemic Control Than Sulfonylureas

DPP4 Inhibitors Provide Greater Long-Term Glycemic Control Than Sulfonylureas

By

Investigators discuss an added benefit of using DPP4 inhibitors would be a lower incidence of hypoglycemia.

Insulin Associated With BMD Loss at Femoral Neck in Women With T2D

Insulin Associated With BMD Loss at Femoral Neck in Women With T2D

By

Bone mineral density was evaluated annually of the lumbar spine and femoral neck.

FDA: Semaglutide Approval for Adults With T2D

FDA: Semaglutide Approval for Adults With T2D

By

Semaglutide, a once-weekly GLP-1 receptor agonist, demonstrated clinically significant reductions in HbA1c among adults with type 2 diabetes.

Voluntary Recall of Diabetes Drug Due to Possible Microbial Contamination

Voluntary Recall of Diabetes Drug Due to Possible Microbial Contamination

By

The Food and Drug Administration has posted a recall notification for 2 lots of Riomet 500mg/5mL due to the possibility that the liquid may be contaminated with Scopulariopsis brevicaulis.

Incident Diabetes May Explain Association Between Sleep Duration and CHD

Incident Diabetes May Explain Association Between Sleep Duration and CHD

By

Interventions targeting sleep duration could have a significant impact on health outcomes when considering the importance of diabetes for a wide range of diseases.

Insulin-Induced Weight Gain Not Associated With Adverse CV Outcomes in T2D

Insulin-Induced Weight Gain Not Associated With Adverse CV Outcomes in T2D

By

Despite the well‐recognized correlation between weight gain and cardiovascular (CV) disease, there is little direct evidence relating to the impact of insulin‐induced weight gain on CV outcomes.

Renal Outcomes in T2D With Intensive Glycemic Control in Veterans

Renal Outcomes in T2D With Intensive Glycemic Control in Veterans

By

Interim analysis of the follow-up Veterans Affairs Diabetes Trial study shows that intensive glycemic control for a median of 5.6 years may have a modest beneficial effect on delaying the progression of renal disease.

No Difference in Cardiovascular Outcomes With Exenatide vs Placebo in T2D

No Difference in Cardiovascular Outcomes With Exenatide vs Placebo in T2D

By

Once-weekly administration of extended-release exenatide in patients with T2D at a wide range of cardiovascular risk appeared not to cause an increase in their overall cardiovascular risk.

Increasing Body Surface Area Affected by Psoriasis May Increase T2D Risk

Increasing Body Surface Area Affected by Psoriasis May Increase T2D Risk

By

For patients with psoriasis, an increase in body surface area affected by the disease may be associated with a greater risk of type 2 diabetes.

Empagliflozin Reduces CVD Risk in Patients With T2D and PAD

Empagliflozin Reduces CVD Risk in Patients With T2D and PAD

By

Empagliflozin lowered the risk of cardiovascular death vs placebo when added to standard of care in adults with both type 2 diabetes and peripheral artery disease.

Brain Glucose Levels Blunted During Hyperglycemia in T2D and Obesity

Brain Glucose Levels Blunted During Hyperglycemia in T2D and Obesity

The rise of brain glucose levels is blunted during hyperglycemia in adults with obesity and type 2 diabetes mellitus.

Once-Weekly Omarigliptin Improves Glycemic Control in Type 2 Diabetes

Once-Weekly Omarigliptin Improves Glycemic Control in Type 2 Diabetes

By

A study of the once-weekly investigational dipeptidyl peptidase-4 omarigliptin reported a clinically meaningful reduction in glycated hemoglobin that was maintained throughout the study.

T2D in African American Women Ups ER-negative Breast Cancer Risk

T2D in African American Women Ups ER-negative Breast Cancer Risk

The high prevalence of T2D in African American women could explain previously identified racial disparities in breast cancer incidence.

High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D

High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D

By

Levels of high sensitivity C-reactive protein may help risk stratify those patients with T2D and recent acute coronary syndrome at further risk of recurrent cardiovascular events.

Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients

Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients

By

The association between statin use and diabetes risk in a cohort of overweight and obese patients was examined.

Insulin Glargine Associated With Breast Cancer Risk in T2D

Insulin Glargine Associated With Breast Cancer Risk in T2D

By

Researchers assessed whether long-term use of long-acting insulin analogs, compared with the use of neutral protamine Hagedorn insulin, is associated with an increased risk of breast cancer in women with T2D.

Change in Urine Albumin-to-Creatinine Ratio May Be a Prognostic Indicator in T2D

Change in Urine Albumin-to-Creatinine Ratio May Be a Prognostic Indicator in T2D

By

Albuminuria may be an effective prognostic indicator of adverse outcomes risk in patients with diabetes.

Bariatric Surgery: An Effective Treatment for Type 2 Diabetes

Bariatric Surgery: An Effective Treatment for Type 2 Diabetes

By

Bariatric surgery appears to induce changes in the gastrointestinal tract and its interactions with the endocrine system in ways that may influence glycemic control.

Acarbose Reduces Diabetes Risk in Coronary Heart Disease

Acarbose Reduces Diabetes Risk in Coronary Heart Disease

By

Acarbose, an α-glucosidase inhibitor, decreased the incidence of diabetes in a population with impaired glucose tolerance who were at low risk of cardiovascular events.

Dementia Risk Reduced With Metformin in Veterans With T2D

Dementia Risk Reduced With Metformin in Veterans With T2D

Metformin is linked to a lower dementia risk compared to sulfonylureas among veterans with type 2 diabetes.

Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i

Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i

By

Researchers evaluated a meta-analysis of randomized controlled trials and an analysis of the FDA AE Reporting System to determine whether combination DPP4i/SGLT2i medication lowers risk of GUTI.

Efficacy of Oral and Subcutaneous Semaglutide in T2D

Efficacy of Oral and Subcutaneous Semaglutide in T2D

By

All dosages of oral semaglutide reduced mean HbA1c level significantly more than placebo by week 26.

Improving NSTEMI Outcomes in T2D With NOCS: Efficacy of Incretin

Improving NSTEMI Outcomes in T2D With NOCS: Efficacy of Incretin

People with type 2 diabetes and NOCS-NSTEMI who used incretin had a better prognosis than non-incretin users.

Severe Hypoglycemia Associated With Increased Mortality Risk in T2D

Severe Hypoglycemia Associated With Increased Mortality Risk in T2D

By

A study confirms whether severe hypoglycemia increases risk for all-cause mortality in patients with type 2 diabetes.

Glucose Patterns and the Future Development of Diabetes

Glucose Patterns and the Future Development of Diabetes

By

Study revealed heterogeneity in plasma glucose response to oral glucose intake beyond the established glucose criteria based on fasting plasma glucose and 2 h post-load plasma glucose levels.

Does Professional CGM Decrease the Economic Burden of T2D?

Does Professional CGM Decrease the Economic Burden of T2D?

By

Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.

Rate of Undiagnosed Diabetes in the United States

Rate of Undiagnosed Diabetes in the United States

By

Undiagnosed diabetes is a relatively small fraction of the total diabetes population when a confirmatory definition is used.

Patient Nonadherence Often Misidentified as Diabetes Treatment Failure

Patient Nonadherence Often Misidentified as Diabetes Treatment Failure

Second-line treatments are often initiated without first using first-line therapies.

Sign Up for Free e-Newsletters

CME Focus